Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Lota S. Zoth files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ronald David Butler II - $524K in FFIN purchases and sales in the last 12 months
- Geoff Haney - $382K in FFIN purchases and sales in the last 12 months
- Sally Pope Davis - $155K in FFIN purchases and sales in the last 12 months
- Johnny Trotter - $149K in FFIN purchases and sales in the last 12 months
- Michelle S. Hickox - $121K in FFIN purchases and sales in the last 12 months
- Michael B. Denny - $104K in FFIN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lota S. Zoth?
Lota S. Zoth is a corporate insider of enGene Therapeutics Inc. (ENGN). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Lota S. Zoth last file a Form 4?
The most recent primary Form 4 on record is dated 17 June 2026, one of 7 filings going back to 2024.